Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Novartis Dealmaking Serves as Cautionary Tale for Pharma M&A
Novartis' latest trial setback serves a cautionary tale for investors betting on big pharma's strategy of making bite-size acquisitions to bolster their drug pipelines. In theory, smaller deals offer big pharma access to promising and potentially…
Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat
Sandoz CEO Richard Saynor warned U.S. patients could ultimately bear the cost of threatened tariffs on imported generic drugs. Saynor said manufacturers facing steep tariffs could be forced to raise prices or stop supplying some medicines. Sandoz…
Amgen: Why Rivals' Cholesterol Drug Fail Is Bad News For Pharma (Rating Downgrade)
Amgen stock fell ~10% after Novartis' Lp(a)-lowering drug pelacarsen failed its Phase 3 cardiovascular outcomes study, raising doubts about its similar program. Olpasiran, AMGN's Lp(a)-lowering candidate, faces heightened skepticism as NVS' data…
Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?
The iShares U.S. Pharmaceuticals ETF (IHE -1.72%) offers concentrated, low-beta pharmaceutical exposure, while Invesco S&P 500 Equal Weight Health Care ETF (RSPH -2.07%) provides equal-weighted access to the broader healthcare sector at a slightly…
Hyderabad-Tashkent flight to strengthen tourism, pharma and healthcare ties, says envoy
A new Hyderabad-Tashkent flight will be among the first tangible outcomes of a renewed push to deepen India-Uzbekistan ties, with Uzbekistan's Ambassador to India Sardor Mirzayusupovich Rustambaev describing the route as an ‘air bridge'…
BridgeBio Pharma, Inc. $BBIO Shares Bought by Squarepoint Ops LLC
Squarepoint Ops LLC boosted its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 114.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional…
NewAmsterdam Pharma (NASDAQ:NAMS) Given 'Buy' Rating at HC Wainwright
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report)'s stock had its 'buy' rating reiterated by HC Wainwright in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $52.00 price objective on the…
Wellington Management Group LLP Reduces Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
Wellington Management Group LLP decreased its stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 95.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional…
TD Cowen Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price
Royalty Pharma (NASDAQ:RPRX - Get Free Report) had its price target boosted by equities researchers at TD Cowen from $65.00 to $68.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a 'buy' rating on the…
Sun Pharma gets ratings boost from Moody's, S&P over ₹11.75-billion Organon & Co acquisition bid
Rating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries -- India's largest pharmaceutical company -- over the proposed $11.75-billion acquisition of US-based Organon & Co. S&P Global Ratings assigned a…
Ex-Dem lobbyist for company that promoted addictive opioid clears key gubernatorial hurdle
Cinde Warmington secured the Democratic nomination in New Hampshire's gubernatorial primary on Tuesday evening after running unopposed. Her nomination marks the second time she's pursued the office as Warmington continues to face attacks over her…
KBR: A Bet On Future Innovation And Global Scale, As Major Spinoff Looms (NYSE:KBR)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Republican John Sununu and Democrat Chris Pappas win New Hampshire Senate primaries, setting up battleground race
The battleground New Hampshire Senate race is set between Republican former Sen. John Sununu and Democratic Rep. Chris Pappas, NBC News projects, after both prevailed in their primaries Tuesday night. Pappas defeated scientist Karishma Manzur, a…
AstraZeneca's experimental COPD treatment posts strong results in late-stage studies
In a pair of late-stage trials, a drug from AstraZeneca reduced the dangerous flare-ups that drive the worsening of COPD, positioning it as a potential new option for the vast numbers of patients with the debilitating lung condition, according to…
Steve Jobs didn't trust focus groups to inform product design. These AI entrepreneurs believe they solved the problem
In a 1998 interview, Steve Jobs was asked whether Apple had done consumer research when developing the iMac. At the time, Apple was trying to revive its fortunes after years of decline, and the iMac—with its radically different, translucent…
Receive a Daily briefing on Pharma Industry News
Get Started